Biodesix, Inc. (BDSX)
NASDAQ: BDSX · Real-Time Price · USD
14.64
-1.11 (-7.05%)
At close: May 13, 2026, 4:00 PM EDT
14.65
+0.01 (0.07%)
After-hours: May 13, 2026, 5:14 PM EDT
Biodesix Market Cap
Biodesix has a market cap or net worth of $147.97 million as of May 13, 2026. Its market cap has increased by 76.43% in one year.
Market Cap
147.97M
Enterprise Value
193.70M
1-Year Change
76.43%
Ranking
Category
Stock Price
$14.64
Market Cap Chart
Since October 28, 2020, Biodesix's market cap has decreased from $336.31M to $147.97M, a decrease of -56.00%. That is a compound annual growth rate of -13.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2026 | 159.19M | 194.26% |
| Dec 31, 2025 | 54.10M | -75.69% |
| Dec 31, 2024 | 222.56M | 33.69% |
| Dec 29, 2023 | 166.48M | -5.38% |
| Dec 30, 2022 | 175.94M | 23.06% |
| Dec 31, 2021 | 142.97M | -73.28% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Personalis | 605.29M |
| Castle Biosciences | 577.48M |
| Fulgent Genetics | 449.30M |
| Myriad Genetics | 397.63M |
| Prenetics Global | 294.83M |
| Burning Rock Biotech | 170.96M |
| Insight Molecular Diagnostics | 157.94M |
| FONAR | 123.51M |